05.05.2022 | COVID-19 | Correction
Correction to: Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination
Erschienen in: International Journal of Hematology | Ausgabe 6/2022
Einloggen, um Zugang zu erhaltenExcerpt
In the original publication of the article, the table related to case study was missing. The case study table is given in this correction.
Case
|
Disease
|
CD20 MoAb*1
|
SARS-CoV2
|
Anti-SARS-CoV-2 Antibodies (AU/mL)*2
|
Serum IgG (mg/dL)*3
|
Time*4
|
|||||
---|---|---|---|---|---|---|---|---|---|---|---|
Infection
|
Vaccine
|
IgG-N
|
IgM-N
|
IgG-S1
|
IgM-S1
|
Nab
|
|||||
Case 1
|
FL
|
37
|
+
|
−
|
n.t.*5
|
n.t
|
n.t
|
n.t
|
0.68
|
563
|
+ 2w
|
0.27
|
0.14
|
0.39
|
0.21
|
3.48
|
441
|
+ 4w
|
|||||
0.19
|
0.33
|
0.37
|
0.23
|
1.44
|
183
|
+ 10w
|
|||||
Case 2
|
FL
|
1
|
+
|
−
|
9.46
|
0.82
|
0.47
|
0.48
|
2.37
|
685
|
+ 2w
|
235.22
|
29.82
|
16.79
|
2.23
|
21.21
|
576
|
+ 4w
|
|||||
Case 3
|
FL
|
12
|
+
|
+
|
0.32
|
1.12
|
7.09
|
594.44
|
140.16
|
492
|
+ 2w
|
0.32
|
0.95
|
8.01
|
578.75
|
213.00
|
461
|
+ 4w
|
|||||
Case 4
|
Healthy
|
0
|
−
|
+
|
0.53
|
0.16
|
9.78
|
0.63
|
5.88
|
1,290
|
+ 2w
|
0.50
|
0.17
|
2145.96
|
18.97
|
2836.82
|
1,291
|
+ 4w
|